Bankers and executives had to work on Christmas Eve and New Year's Day, though they took a break for Christmas.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Eli Lilly shares slide premarket on news of failed trial for sarcoma treatment
Baca lebih lajut »
Stocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & moreSome of the names on the move ahead of the open.
Baca lebih lajut »
Stocks making the biggest moves midday: Netflix, Boeing, Tesla, Eli Lilly & moreCheck out the companies making headlines midday Friday.
Baca lebih lajut »
Lilly cancer drug fails key trial, will no longer be prescribedEli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had wo...
Baca lebih lajut »
Lilly's cancer therapy Lartruvo fails study, shares dropEli Lilly and Co said on Friday its cancer treatment Lartruvo, approved on an ac...
Baca lebih lajut »
Lilly eyes more cancer deals, but wary of CAR-T, gene therapyEli Lilly and Co remains in the hunt for cancer drugs even after announcing an $...
Baca lebih lajut »
Eli Lilly’s Sarcoma Drug Combo Proves Ineffective in TrialsEli Lilly said it would stop promoting Lartruvo, a relatively new cancer drug, after a study found it didn’t significantly prolong the lives of patients when used in combination with an older drug.
Baca lebih lajut »
House Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices.
Baca lebih lajut »
From Amgen to Gilead, drugmakers are sitting on billions of cash — and top pharma executives are hinting about big M&A to come in 2019Billion-dollar deals from drug giants Eli Lilly & Co. and Bristol-Myers Squibb could set the tone for a year full of healthcare acquisitions.
Baca lebih lajut »